FTY720 enhances the efficacy of paclitaxel and of carboplatin in drug-resistant ovarian cancer cells

被引：0
|
作者：
Kreitzburg, Kelly M.
Alvarez, Ronald D.
Landen, Charles N.
Yoon, Karina J.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-316
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
316
引用
收藏
页数：3
相关论文
共 50 条
  • [31] FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1
    Xing, Ying
    Wang, Zhi Hong
    Ma, Dong Hong
    Han, Ying
    JOURNAL OF DIGESTIVE DISEASES, 2014, 15 (05) : 246 - 259
  • [32] The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
    Hait, N. C.
    Avni, D.
    Yamada, A.
    Nagahashi, M.
    Aoyagi, T.
    Aoki, H.
    Dumur, C. I.
    Zelenko, Z.
    Gallagher, E. J.
    Leroith, D.
    Milstien, S.
    Takabe, K.
    Spiegel, S.
    ONCOGENESIS, 2015, 4 : e156 - e156
  • [33] FTY720 Inhibits Expansion of Breast Cancer Stem Cells via PP2A Activation
    Hirata, Naoya
    Yamada, Shigeru
    Yanagida, Shota
    Ono, Atsushi
    Kanda, Yasunari
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [34] Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro
    Marvaso, Giulia
    Barone, Agnese
    Amodio, Nicola
    Raimondi, Lavinia
    Agosti, Valter
    Altomare, Emanuela
    Scotti, Valerio
    Lombardi, Angela
    Bianco, Roberto
    Bianco, Cataldo
    Caraglia, Michele
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    CANCER BIOLOGY & THERAPY, 2014, 15 (06) : 797 - 805
  • [35] FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells
    Tonelli, Francesca
    Lim, Keng Gat
    Loveridge, Carolyn
    Long, Jaclyn
    Pitson, Stuart M.
    Tigyi, Gabor
    Bittman, Robert
    Pyne, Susan
    Pyne, Nigel J.
    CELLULAR SIGNALLING, 2010, 22 (10) : 1536 - 1542
  • [36] FTY720/Fingolimod mitigates paclitaxel-induced Sparcl1-driven neuropathic pain and breast cancer progression
    Singh, Sandeep K.
    Weigel, Cynthia
    Brown, Ryan D. R.
    Green, Christopher D.
    Tuck, Connor
    Salvemini, Daniela
    Spiegel, Sarah
    FASEB JOURNAL, 2024, 38 (15):
  • [37] Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells
    Patel, Nish
    Chatterjee, Sabarni K.
    Vrbanac, Vladimir
    Chung, Ivy
    Mu, Chunyao Jenny
    Olsen, Rachelle R.
    Waghorne, Carol
    Zetter, Bruce R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (06) : 2503 - 2508
  • [38] Antiproliferative effect of fingolimod (FTY720) in human prostate cancer cells: Insights to estrogen metabolism in situ
    Allam, Rasha M.
    Mosli, Hisham A.
    Khalifa, Amany E.
    Nofal, Salwa M.
    Sharaf, Ola A.
    Abdel-Naim, Ashraf B.
    Al-Abd, Ahmed M.
    CANCER RESEARCH, 2014, 74 (19)
  • [39] Immunomodulatory drug FTY720 induces regulatory CD4+CD25+ T cells in vitro
    Zhou, P. J.
    Wang, H.
    Shi, G. H.
    Wang, X. H.
    Shen, Z. J.
    Xu, D.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 157 (01): : 40 - 47
  • [40] FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1
    Pchejetski, Dmitri
    Bohler, Torsten
    Brizuela, Leyre
    Sauer, Lysann
    Doumerc, Nicolas
    Golzio, Muriel
    Salunkhe, Vishal
    Teissie, Justin
    Malavaud, Bernard
    Waxman, Jonathan
    Cuvillier, Olivier
    CANCER RESEARCH, 2010, 70 (21) : 8651 - 8661
12345